According to an article on CancerNetwork by Anna Azvolinsky, PhD, "epidemiological evidence as well as evidence from recent randomized trials suggest that aspirin may be of use in the adjuvant setting to treat cancer.”
The article continues, “Recent randomized trials that have aimed to show that aspirin can help to prevent cardiovascular disease have also shown a reduction in cancer incidence with long-term patient follow-up. Other traditional nonsteroidal anti-inflammatory drugs (NSAIDs) have also been shown to play a role in cancer risk reduction.”
To read the original article, click here.
Source: CancerNetwork